TransCode Therapeutics, Inc. (RNAZ)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 0.7070 |
| Open | 0.7500 |
| Bid | 0.7946 x 100 |
| Ask | 0.8456 x 100 |
| Day's range | 0.6950 - 1.0500 |
| 52-week range | 0.4200 - 309.6000 |
| Volume | |
| Avg. volume | 437,029 |
| Market cap | 4.763M |
| Beta (5Y monthly) | -0.34 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
TransCode (RNAZ) Down 50% on Issue of New Common Stock
TransCode Therapeutics (RNAZ) will issue secondary shares and warrants, diluting its current shareholder base. The company plans to raise $7.5 million in gross proceeds from this issue.
- Zacks
TransCode Therapeutics Inc. (RNAZ) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
TransCode Therapeutics Inc. (RNAZ) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
© 2024 Yahoo. All rights reserved.